IMVT vs NXPI · $2.90B cap vs P/E 29, rev $12.27B
Immunovant Inc (IMVT) versus NXP Semiconductors NV (NXPI) — a side-by-side from cached financials, not a winner call.
Immunovant Inc (IMVT) is a biotechnology company listed on US.
NXP Semiconductors NV (NXPI) is a semiconductors company listed on NASDAQ.
IMVT does not have a complete income-statement cache yet.
Latest reported NXPI revenue for 2025-12-31 was $12.27B. Net income was $2.02B. Revenue was down 2.7% from 2024-12-31 to 2025-12-31. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
IMVT currently screens at market cap $2.90B. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
Not investment advice. Open the IMVT and NXPI stock pages for the full models.
Not investment advice.